Organism name | Maytenus cuzcoina |
---|---|
Genus | Maytenus |
Family | Celastraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Maytenus |
---|---|
Linked NCBI taxonomy ID | 123430 |
Linked level | genus |
Family in NCBI taxonomy | Celastraceae |
---|---|
ID | 4305 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003740 C00019220 C00034390 C00035253 C00042123 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003740 C00003749 C00034390 C00035253 C00042123 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00003740 C00019220 C00034390 C00035253 C00042123 | 0 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | C00003740 C00003749 C00034390 C00035253 C00042123 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00003740 C00034390 C00035253 C00042123 | 11 / 10 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003740 C00034390 C00042123 | 1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003740 C00034390 C00042123 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00003740 C00034390 C00042123 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003740 C00034390 C00042123 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003740 C00034390 C00042123 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003740 C00034390 C00042123 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003740 C00034390 C00042123 | 0 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003740 C00034390 C00042123 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00003740 C00034390 C00042123 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00003740 C00042123 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00003740 C00042123 | 3 / 1 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003740 C00042123 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003740 C00042123 | 0 / 3 |
O75496 | Geminin | Unclassified protein | C00034390 C00035253 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00034390 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00034390 | 0 / 0 |
P08151 | Zinc finger protein GLI1 | Unclassified protein | C00034390 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00034390 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00034390 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00034390 | 1 / 1 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00034390 | 0 / 0 |
P15559 | NAD(P)H dehydrogenase [quinone] 1 | Enzyme | C00034390 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00019220 | 4 / 2 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003749 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00034390 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00034390 | 0 / 0 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00034390 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00034390 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00034390 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00034390 | 2 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00035253 | 4 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00035253 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00034390 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00034390 | 1 / 0 |
Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00034390 | 0 / 0 |
Q9UBT2 | SUMO-activating enzyme subunit 2 | Enzyme | C00034390 | 0 / 0 |
Q9UBE0 | SUMO-activating enzyme subunit 1 | Unclassified protein | C00034390 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00003749
|
5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00003749
|
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003110 | Colonic Neoplasms |
C00003740
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00003740
|
D006528 | Carcinoma, Hepatocellular |
C00003749
|
D009202 | Cardiomyopathies |
C00003749
|
D006937 | Hypercholesterolemia |
C00003749
|
D009374 | Neoplasms, Experimental |
C00003749
|
D012878 | Skin Neoplasms |
C00003749
|
D014947 | Wounds and Injuries |
C00003749
|